Home | Current Issue | Previous Issues | Subscription | Advertistment | Guidelines | Contact ASN |
ACTA
|
Table of Contents for
Jun 2016 • Volume 32 • Number 73 |
HOW MUCH WE KNOW ABOUT BISPHOSPHONATE LESIONS
Zoran Pešić 1, Miloš Zarev 2, Jovana Ranđelović 2
1Clinic of Dentistry, Department of Maxillofacial Surgery, Nis, Serbia 2University of Nis, Faculty of Medicine, PhD students |
|
...Abstract |
Introduction: Bisphosphonate drugs
are used in the treatment of the osteoporosis and malignant processes in
the bone tissue. As a result of this use bisphosphonate lesions are
formed in bone tissue and oral mucosis, which representing a
remarkable therapeutic problem. Matreijal and Methods: An anonymous questionnaire of 13 questions was conducted in dental practices in Nis County in the period from October 2015 to December 2015. The obtained data were statistically analyzed. Results: A total of 60% dentists knew what drugs are used in the treatment of osteoporosis and malignant processes in the bones. 25% knew what the bisphosphonate bone lesions are . 66, 6% of dentists knewn what is the prevention of bisphosphonate lesions. 63.3% of dentists are aware of the complications bisphosphonate lesions. Conclusion: Dentists in general practices are insufficiently familiar with the character, diagnosis and treatment of bisphosphonate lesions. We should activate all entities that participate in more continuous medical education, in order to achieve a higher level of prevention of these therapeutic ungrateful lesions.
|
... Authors and Reprint Information |
Address of correspondence: Prof. Zoran Pešić, DDS,PhD Dr Zoran Đinđić Blvd.52, 18000 Niš, phone:+38169469619 email.pesic.z@gmail.com
|